ACCESSION: MSBNK-SMB_Measured-HSA008R0263000
RECORD_TITLE: Alpha-N-Phenylacetyl-glutamine; LC-ESI-QTOF; MS2; NEGATIVE; Generated from DDA dataset; Annotation confidence level 3
DATE: 2025.09.27
AUTHORS: Ryosuke Hayasaka, Akiyoshi Hirayama (Keio Univ.), and Fumio Matsuda (Univ. Osaka)
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
PROJECT: Shin-MassBank project supported by JST
COMMENT: Annotation confidence level 3. The metabolite structure was manually curated by the Shin-MassBank project. This metabolite is found from more than five datasets with confidence level 3
COMMENT: The metabolite structure was automatically characterized by the Shin-MassBank project (see COMMENT: CONFIDENCE). One of the possible structures is shown. The record should be used with caution.
COMMENT: This is an averaged mass spectra data created by averaging 150 product ion spectra among 60 DDA data files in the dataset described below.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS417
COMMENT: DATASET_TITLE Customized Consensus Spectral Library Building for Untargeted Quantitative Metabolomics Analysis with Data Independent Acquisition Mass Spectrometry and MetaboDIA Workflow
COMMENT: DATASET_AUTHORS Zhou Lei, Hyungwon Choi
COMMENT: PRECURSOR_IN_MS1 mz 263.103653; int 736.993; delta(ppm) -1.140025
COMMENT: PROPOSED_MF SevenGoldenRules 1.174; C13H16N2O4; [M-H]1; delta(ppm) 1.173748; Ranking 1;
COMMENT: PROPOSED_MF MS-FINDER 4.578; C13H16N2O4; [M-H]-; delta(ppm) 1.179834; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS5_Sirius 26.448; C13H16N2O4; [M-H]-; delta(ppm) 1.179834; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C13H16N2O4; [M-H]-; delta(ppm) 1.179834; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS6_Sirius 38.422; C13H16N2O4; [M-H]-; delta(ppm) 1.179834; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.999; C13H16N2O4; [M-H]-; delta(ppm) 1.179834; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 3.000; JFLIEFSWGNOPJJ-JTQLQIEISA-N; C13H16N2O4; PHENYLACETYL-GLUTAMINE; Ranking 1;
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.656; JFLIEFSWGNOPJJ-JTQLQIEISA-N; [M-H]-; NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(O)=O; Ranking 1;
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.700; JFLIEFSWGNOPJJ-JTQLQIEISA-N; [M-H]-; Alpha-N-Phenylacetyl-L-glutamine; Ranking 1;
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.741; JFLIEFSWGNOPJJ-JTQLQIEISA-N; [M-H]-; Alpha-N-Phenylacetyl-L-glutamine; Ranking 3;
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.938; JFLIEFSWGNOPJJ-JTQLQIEISA-N; [M-H]-; (2S)-5-amino-5-oxo-2-[(2-phenylacetyl)amino]pentanoic acid; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -4.561; JFLIEFSWGNOPJJ; [M-H]-; PA-L-Glutamine; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.985; JFLIEFSWGNOPJJ; [M-H]-; PA-L-Glutamine; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.379; JFLIEFSWGNOPJJ; [M-H]-; Phenylacetylglutamine; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.996; JFLIEFSWGNOPJJ; [M-H]-; Phenylacetylglutamine; Ranking 1;
COMMENT: CONFIDENCE Tentative candidate (Level 3); Proposed by SIRIUS6_Confidence (FDR < 0.1); Similarity by SIMILARITY:GNPS (Dot product > 0.7, 3 spectra); Supported by CFM-ID:MsfinderDB (Ranking 1), MS-FINDER:MsfinderDB (Ranking 1), MetFrag:MsfinderDB (Ranking 3), MetFrag:PubchemLite (Ranking 1); Biological context by HMDB (HMDB0006344)
CH$NAME: Alpha-N-Phenylacetyl-glutamine
CH$NAME: Phenylacetylglutamine
CH$NAME: 5-amino-5-keto-2-[(2-phenylacetyl)amino]valeric acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C13H16N2O4
CH$EXACT_MASS: 264.111007
CH$SMILES: C1=CC=C(C=C1)CC(=O)NC(CCC(=O)N)C(=O)O
CH$IUPAC: InChI=1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)
CH$LINK: HMDB HMDB0006344
CH$LINK: INCHIKEY JFLIEFSWGNOPJJ-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:306137
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: TripleTOF 5600+, AB Sciex
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 20 to 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 10.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC HSS T3 (3 Âµm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was 2% B from 0 to 1.5 min, 20% B at 7.5 min, 50% B at 12 min, 95% B from 16 to 18 min, and 2% B at 19 to 25 min
AC$CHROMATOGRAPHY: FLOW_RATE 0.35 ml/mi
AC$CHROMATOGRAPHY: RETENTION_TIME 3.715
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 263.104041
MS$DATA_PROCESSING: COMMENT Product ions not positively corelated with the precursor ion were removed (rank order correlation, alpha = 0.01).
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-002b-0900000000-302cfcb46d2336a16f50
PK$ANNOTATION: m/z int mzPAF cor n
  101.071804 29 f{C4H9N2O1}/-2.30ppm,p-C9H6O3 0.9241 123
  109.040456 173 f{C5H5N2O1}/-2.57ppm,p-C8H10O3 0.9530 138
  127.051245 455 f{C5H7N2O2}/-0.44ppm,p-C8H8O2 0.9574 150
  128.034940 125 f{C5H6N1O3}/-2.94ppm,p-C8H9N1O1 0.9584 129
  145.061785 999 f{C5H9N2O3}/-0.55ppm,p-C8H6O1 0.9490 150
  263.103280 70 f{C13H15N2O4}/-1.71ppm,p 1.0000 147
PK$NUM_PEAK: 6
PK$PEAK: m/z int. rel.int.
  101.071804 29.00 29
  109.040456 173.00 173
  127.051245 455.00 455
  128.034940 125.00 125
  145.061785 999.00 999
  263.103280 70.00 70
//
